These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32194805)

  • 21. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma.
    Huang Q; Qu T; Qi L; Liu C; Guo Y; Guo Q; Li G; Wang Y; Zhang W; Zhao W; Ren D; Sun L; Wang S; Meng B; Sun B; Zhang B; Ma W; Cao W
    Cancer Biol Med; 2021 Mar; 18(2):517-29. PubMed ID: 33710816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multigene panel predicting survival of patients with colon cancer.
    Li HD; Liang C
    J Cancer; 2019; 10(27):6792-6800. PubMed ID: 31839813
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma.
    Song Q; Shang J; Yang Z; Zhang L; Zhang C; Chen J; Wu X
    J Transl Med; 2019 Mar; 17(1):70. PubMed ID: 30832680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma.
    Huang S; Zhao M; Li S; Chen T; Zhong Y; Deng J; Xu L; Wu J; Xie X; Wu C; Hou L; She Y; Zheng H; Chen C
    Lung Cancer; 2024 Mar; 189():107472. PubMed ID: 38320371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
    Ma B; Geng Y; Meng F; Yan G; Song F
    J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375
    [No Abstract]   [Full Text] [Related]  

  • 28. Lepidic component identifies a subgroup of lung adenocarcinoma with a distinctive prognosis: a multicenter propensity-matched analysis.
    Zhu E; Dai C; Xie H; Su H; Hu X; Li M; Fan J; Liu J; Zhu Q; Zhang L; Ke H; Chen C
    Ther Adv Med Oncol; 2020; 12():1758835920982845. PubMed ID: 33488781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.
    Bucciarelli PR; Tan KS; Chudgar NP; Brandt W; Montecalvo J; Eguchi T; Liu Y; Aly R; Travis WD; Adusumilli PS; Jones DR
    J Thorac Oncol; 2018 Jan; 13(1):73-84. PubMed ID: 29097253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA-DQB1 expression on tumor cells is a novel favorable prognostic factor for relapse in early-stage lung adenocarcinoma.
    Zhang L; Li M; Deng B; Dai N; Feng Y; Shan J; Yang Y; Mao C; Huang P; Xu C; Wang D
    Cancer Manag Res; 2019; 11():2605-2616. PubMed ID: 31114327
    [No Abstract]   [Full Text] [Related]  

  • 31. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L; Wang H; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    PLoS One; 2020; 15(5):e0233283. PubMed ID: 32437446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a 5-Gene Metabolic Signature for Predicting Prognosis Based on an Integrated Analysis of Tumor Microenvironment in Lung Adenocarcinoma.
    Yu X; Zhang X; Zhang Y
    J Oncol; 2020; 2020():5310793. PubMed ID: 32684932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of a 9-Gene Prognostic Signature in Patients With Multiple Myeloma.
    Liu XP; Yin XH; Meng XY; Yan XH; Wang F; He L
    Front Oncol; 2018; 8():615. PubMed ID: 30671382
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
    Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
    Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
    J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-scale pathology image texture signature is a prognostic factor for resectable lung adenocarcinoma: a multi-center, retrospective study.
    Wang Y; Pan X; Lin H; Han C; An Y; Qiu B; Feng Z; Huang X; Xu Z; Shi Z; Chen X; Li B; Yan L; Lu C; Li Z; Cui Y; Liu Z; Liu Z
    J Transl Med; 2022 Dec; 20(1):595. PubMed ID: 36517832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.
    Liu C; Li Z; Wang S; Fan Y; Zhang S; Yang X; Hou K; Tong J; Hu X; Shi X; Wang X; Liu Y; Che X; Qu X
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):65-76. PubMed ID: 30357521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.
    Chen H; Ma X; Yang M; Wang M; Li L; Huang T
    Front Genet; 2020; 11():333. PubMed ID: 32391054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High
    Xie L; Dang Y; Guo J; Sun X; Xie T; Zhang L; Yan Z; Amin H; Guo X
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma.
    Wang Y; Deng H; Xin S; Zhang K; Shi R; Bao X
    Front Genet; 2019; 10():349. PubMed ID: 31105737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.